…ients with CHD with and without cirrhosis who were treated with BLV 2 mg for up to 144W reported improvements in their perceived he…
BLV
This drug is selected. Its supporting articles are shown below.
Articles mentioning BLV
6 articles · page 1 of 1…10 mg monotherapy (n=50), (B) BLV 10 mg for 96W (n=100), or (C) BLV 10 mg for 144W (n=50). Patient follow-up (FU) continued for 48W…
…is the most severe form of viral hepatitis. The entry inhibitor bulevirtide (BLV) was recently approved for treatment, but validated predic…
…r 10 mg/day for 144W or to 48W of delayed treatment followed by BLV 10 mg/day for 96W (DT-to-10 mg) and 96W posttreatment FU. Effic…
…subset of patients with chronic hepatitis delta (CHD) receiving bulevirtide (BLV) monotherapy achieved undetectable hepatitis delta virus (…
…nkage to specialist care, including access to licensed therapy, bulevirtide (BLV), and recruitment into clinical trials of novel therapies …